Announcement under Regulation 31A (LODR)-(8)(a) Receipt of request 16 Oct - Epsilon Bidco sold 84.48 million shares (26.37%) and requested promoter-to-public reclassification.
Source: Bse
Industrials stocks · Micro cap · NSE
EPL is the largest global specialty packaging company, manufacturing laminated plastic tubes for FMCG and Pharma. It operates 21 manufacturing facilities across 11 countries, employing 6000+ people. It serves categories like Oral Care, Beauty & Cosmetics, Pharma, Home, and Industrial.
SMA20 -4.9% / mo · MACD +
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Mixed fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is mixed.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +25.3% · PAT +0.0% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
PAT 0% YoY · margin compression · Rev +25% YoY · +7% QoQ
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹1,388 Cr | +25.3% | +6.8% |
| EBITDA | ₹261 Cr | +15.0% | +2.0% |
| Operating margin | 19.0% | -100 bps | -100 bps |
| PAT | ₹101 Cr | +0.0% | -1.9% |
| PAT margin | 7.3% | -184 bps | -64 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 19/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Signals are conflicting — long-term uptrend intact. RSI 43. Wait for confirmation.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 56 · legacy U-Score band FAIR VALUE · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
For this sector, IndiaPulse uses a blended lens rather than relying on a single valuation ratio.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Q4FY26 revenue grew 17.6% YoY with 20.2% EBITDA margin. FY26 revenue grew 13.0% YoY with 20.4% EBITDA margin, up 49bps. PAT (ex-exceptional) increased 1% in Q4 and 15.0% for FY26, with EPS at Rs.13.03/share.
EPL delivered strong FY26 results, driven by robust B&C growth and regional expansion. Consistent 20%+ EBITDA margins for seven quarters and improved ROCE indicate operational efficiency. While Q4 PAT was impacted by forex and ETR, full-year growth remains solid. Input cost inflation is a watchpoint.
Latest issuer-disclosed distribution across 4 reported categories.
Delivered 29.9% growth for Q4 and 29.3% for FY26, fueled by strong momentum across regions.
Delivered solid growth of 24% for Q4 and 21% for FY26 with broad based growth, Brazil continues strong.
Delivered robust growth of 25% in Q4 driven by B&C momentum and focus on premium segment growth in Oral.
Personal Care & Beyond grew by 23%+ in FY26, now 53% of total revenue, accelerating driven by strategic focus.
Platina is a benchmark for sustainable solutions, certified through APR and CIPET, with 38% of portfolio now sustainable.
Oral care in AMESA is showing signs of improvement which will support growth going forward.
Middle East crisis impacting availability and pricing of key raw materials; C6/C8 Polymers +71% QoQ, C4 Polymers +40% QoQ, Aluminium Foil +52% QoQ.
Q4 PAT* increased by 1% vs last year, primarily due to INR 104mn Fx loss in this year vs INR 34mn Fx gain in PY.
Lower PAT* growth in Q4 is due to higher ETR due to phasing impact.
Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in such statements.
Intense competition in packaging industry including factors which may affect our cost advantage.
Middle East crisis impacting availability and pricing of key raw materials.
Risks and uncertainties include client concentration.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
The presentation provides detailed YoY comparisons for both Q4 and the full fiscal year, crucial for assessing overall business health and annual trends. However, it also highlights QoQ input cost surges, making sequential analysis relevant for margin sustainability.
Full year revenue growth at 13.0%.
Full year EBITDA growth at 15.8%.
EBITDA margin at 20.4%, +49bps over PY.
PAT* has grown by 15.0%.
With continued B&C focus and execution discipline, we remain confident in sustaining double digit growth.
Targets & Initiatives include consistent margin improvement and robust Capital Deployment model.
Targets & Initiatives include Geographical Expansion with Thailand and M&A.
Targets & Initiatives include Operational Efficiencies in NWC and asset utilization.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| B&C Growth | 29.3% for FY26 | Sustained double-digit growth across regions. |
| EBITDA Margin | 20.4% for FY26 | Continued 20%+ margin delivery and further expansion. |
| Recyclable Portfolio Share | 38% of portfolio in FY26 | Continued scaling up of sustainable tube volumes. |
| Input Cost Pass-through | Focused on full pass-through of cost inflation. | Ability to fully pass through raw material cost increases while maintaining robust absolute EBITDA growth. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 75th percentile of the scored universe and 73rd percentile within Industrials. No major sub-score weakness stands out.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Industrials: 73rd pctile, median 68 · Micro: 56th pctile, median 73
128 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse